Kurt Beam
Concepts (321)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Calcium Channels, L-Type | 57 | 2022 | 107 | 9.700 |
Why?
| Ryanodine Receptor Calcium Release Channel | 37 | 2023 | 59 | 6.810 |
Why?
| Calcium | 57 | 2023 | 1104 | 4.400 |
Why?
| Calcium Channels | 48 | 2012 | 146 | 4.350 |
Why?
| Muscle Fibers, Skeletal | 27 | 2022 | 185 | 3.840 |
Why?
| Muscle, Skeletal | 43 | 2023 | 1477 | 3.560 |
Why?
| Ion Channel Gating | 18 | 2015 | 83 | 3.100 |
Why?
| Calcium Signaling | 17 | 2021 | 213 | 3.090 |
Why?
| Muscle Contraction | 34 | 2012 | 399 | 2.500 |
Why?
| Muscles | 38 | 2008 | 324 | 2.200 |
Why?
| Excitation Contraction Coupling | 8 | 2022 | 17 | 1.900 |
Why?
| Nerve Tissue Proteins | 5 | 2018 | 531 | 1.770 |
Why?
| Muscle Proteins | 15 | 2017 | 210 | 1.660 |
Why?
| Muscular Diseases | 11 | 2016 | 106 | 1.420 |
Why?
| Malignant Hyperthermia | 6 | 2023 | 7 | 1.350 |
Why?
| Neurons | 8 | 2021 | 1285 | 1.280 |
Why?
| Membrane Potentials | 23 | 2013 | 249 | 1.210 |
Why?
| Mice | 76 | 2023 | 14934 | 1.110 |
Why?
| Cell Membrane | 10 | 2021 | 681 | 1.100 |
Why?
| Cells, Cultured | 39 | 2018 | 3897 | 1.070 |
Why?
| Animals | 111 | 2023 | 31884 | 1.040 |
Why?
| Luminescent Proteins | 10 | 2012 | 165 | 1.010 |
Why?
| Animals, Newborn | 20 | 2018 | 779 | 0.980 |
Why?
| Mutation | 13 | 2023 | 3350 | 0.880 |
Why?
| Action Potentials | 16 | 2022 | 406 | 0.810 |
Why?
| Electrophysiology | 24 | 2012 | 201 | 0.790 |
Why?
| Sarcoplasmic Reticulum | 13 | 2017 | 43 | 0.780 |
Why?
| Calcium Channels, N-Type | 1 | 2021 | 5 | 0.760 |
Why?
| Recombinant Fusion Proteins | 12 | 2016 | 616 | 0.730 |
Why?
| Mutation, Missense | 3 | 2013 | 296 | 0.730 |
Why?
| Caveolin 1 | 3 | 2017 | 20 | 0.720 |
Why?
| Motor Neurons | 9 | 1999 | 212 | 0.710 |
Why?
| Endoplasmic Reticulum | 1 | 2021 | 234 | 0.640 |
Why?
| Rabbits | 19 | 2018 | 750 | 0.640 |
Why?
| Membrane Proteins | 2 | 2022 | 1019 | 0.620 |
Why?
| Ion Channels | 9 | 1988 | 124 | 0.570 |
Why?
| Myocardium | 11 | 2012 | 925 | 0.560 |
Why?
| Cell Line | 9 | 2021 | 2645 | 0.560 |
Why?
| Mice, Mutant Strains | 17 | 2012 | 272 | 0.540 |
Why?
| Mutant Proteins | 1 | 2016 | 95 | 0.520 |
Why?
| Calcium Channel Blockers | 11 | 2009 | 115 | 0.500 |
Why?
| Amino Acid Sequence | 15 | 2015 | 1990 | 0.480 |
Why?
| DNA, Complementary | 14 | 2012 | 258 | 0.460 |
Why?
| Kinetics | 15 | 2016 | 1558 | 0.450 |
Why?
| Myoblasts, Skeletal | 2 | 2010 | 11 | 0.440 |
Why?
| Molecular Sequence Data | 15 | 2015 | 2797 | 0.440 |
Why?
| Heart | 5 | 2001 | 613 | 0.440 |
Why?
| Neuromuscular Junction | 5 | 2009 | 53 | 0.430 |
Why?
| Dihydropyridines | 9 | 2003 | 14 | 0.430 |
Why?
| Ryanodine | 3 | 2009 | 13 | 0.410 |
Why?
| Protein Subunits | 6 | 2016 | 201 | 0.410 |
Why?
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 7 | 2013 | 11 | 0.410 |
Why?
| Receptors, Nicotinic | 10 | 1991 | 275 | 0.400 |
Why?
| Adaptor Proteins, Signal Transducing | 4 | 2022 | 371 | 0.380 |
Why?
| Patch-Clamp Techniques | 9 | 2010 | 241 | 0.370 |
Why?
| Muscle, Striated | 1 | 2010 | 5 | 0.360 |
Why?
| Protein Binding | 8 | 2018 | 1898 | 0.360 |
Why?
| Purkinje Cells | 3 | 1999 | 66 | 0.350 |
Why?
| Sodium Channels | 3 | 1999 | 62 | 0.340 |
Why?
| Microtubules | 4 | 1999 | 237 | 0.330 |
Why?
| Protein Structure, Tertiary | 6 | 2015 | 798 | 0.330 |
Why?
| HEK293 Cells | 2 | 2022 | 590 | 0.330 |
Why?
| Myofibrils | 1 | 2009 | 46 | 0.330 |
Why?
| Synaptic Transmission | 4 | 2009 | 228 | 0.320 |
Why?
| Calcium Channel Agonists | 4 | 2013 | 10 | 0.320 |
Why?
| Protein Conformation | 9 | 2010 | 811 | 0.310 |
Why?
| Monomeric GTP-Binding Proteins | 1 | 2008 | 5 | 0.300 |
Why?
| Streptavidin | 1 | 2007 | 15 | 0.300 |
Why?
| Binding Sites | 5 | 2018 | 1173 | 0.290 |
Why?
| Spinal Cord | 3 | 1999 | 349 | 0.280 |
Why?
| Structure-Activity Relationship | 7 | 2010 | 503 | 0.260 |
Why?
| Transfection | 6 | 2012 | 872 | 0.260 |
Why?
| Green Fluorescent Proteins | 6 | 2005 | 373 | 0.260 |
Why?
| Protein Structure, Secondary | 6 | 2012 | 325 | 0.250 |
Why?
| omega-Conotoxins | 2 | 1996 | 3 | 0.240 |
Why?
| Protein Isoforms | 2 | 2021 | 339 | 0.240 |
Why?
| Models, Biological | 8 | 2010 | 1638 | 0.230 |
Why?
| Potassium | 5 | 2006 | 128 | 0.230 |
Why?
| Rats | 14 | 2018 | 4980 | 0.230 |
Why?
| Halothane | 1 | 2023 | 5 | 0.220 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2023 | 9 | 0.220 |
Why?
| Heat-Shock Response | 1 | 2023 | 46 | 0.220 |
Why?
| Calcium Channels, T-Type | 1 | 2003 | 16 | 0.210 |
Why?
| Sequence Homology, Amino Acid | 6 | 2008 | 353 | 0.210 |
Why?
| Myocardial Contraction | 3 | 2012 | 314 | 0.210 |
Why?
| Sinoatrial Node | 1 | 2022 | 27 | 0.210 |
Why?
| Signal Transduction | 9 | 2017 | 4527 | 0.210 |
Why?
| Fluorescence Resonance Energy Transfer | 3 | 2012 | 171 | 0.200 |
Why?
| Microscopy, Confocal | 4 | 2005 | 305 | 0.200 |
Why?
| Sodium | 5 | 2011 | 183 | 0.200 |
Why?
| Electric Conductivity | 10 | 1998 | 88 | 0.190 |
Why?
| Mice, Knockout | 4 | 2016 | 2586 | 0.190 |
Why?
| Bacterial Proteins | 4 | 2012 | 736 | 0.190 |
Why?
| Cytoplasm | 3 | 2012 | 256 | 0.190 |
Why?
| Cerebellum | 2 | 2018 | 200 | 0.170 |
Why?
| Lambert-Eaton Myasthenic Syndrome | 2 | 1996 | 3 | 0.170 |
Why?
| Receptor Cross-Talk | 1 | 1999 | 20 | 0.170 |
Why?
| Manganese | 2 | 2009 | 55 | 0.160 |
Why?
| Biotinylation | 2 | 2012 | 27 | 0.160 |
Why?
| Electric Stimulation | 8 | 2004 | 261 | 0.160 |
Why?
| Prosencephalon | 1 | 2018 | 45 | 0.160 |
Why?
| Mice, Neurologic Mutants | 1 | 1998 | 19 | 0.160 |
Why?
| Myocytes, Cardiac | 1 | 2022 | 451 | 0.160 |
Why?
| Humans | 18 | 2022 | 115222 | 0.160 |
Why?
| Mice, Transgenic | 4 | 2012 | 1956 | 0.150 |
Why?
| Blood Proteins | 1 | 2000 | 233 | 0.150 |
Why?
| Alternative Splicing | 1 | 1999 | 188 | 0.150 |
Why?
| Gene Expression Regulation | 3 | 2016 | 2330 | 0.140 |
Why?
| Ions | 2 | 2008 | 59 | 0.140 |
Why?
| Nervous System Diseases | 1 | 2000 | 253 | 0.140 |
Why?
| Chimera | 2 | 1996 | 59 | 0.140 |
Why?
| Subcellular Fractions | 1 | 2016 | 78 | 0.140 |
Why?
| Recombinant Proteins | 3 | 2014 | 1237 | 0.130 |
Why?
| Electrophysiological Phenomena | 1 | 2016 | 48 | 0.130 |
Why?
| Oxadiazoles | 2 | 1992 | 32 | 0.120 |
Why?
| Caffeine | 5 | 2012 | 57 | 0.120 |
Why?
| Fluorescence | 2 | 2012 | 148 | 0.120 |
Why?
| DNA | 7 | 1993 | 1353 | 0.120 |
Why?
| Receptors, Purinergic P1 | 1 | 1994 | 23 | 0.120 |
Why?
| Hippocampus | 1 | 2018 | 697 | 0.120 |
Why?
| Motor Endplate | 3 | 1986 | 14 | 0.110 |
Why?
| Bone and Bones | 1 | 1996 | 282 | 0.110 |
Why?
| Rats, Sprague-Dawley | 1 | 2018 | 2216 | 0.110 |
Why?
| Plasmids | 6 | 1994 | 345 | 0.110 |
Why?
| Cell Fusion | 2 | 1990 | 50 | 0.110 |
Why?
| Triclosan | 1 | 2012 | 9 | 0.100 |
Why?
| Adenosine | 1 | 1994 | 204 | 0.100 |
Why?
| Molecular Docking Simulation | 1 | 2012 | 102 | 0.100 |
Why?
| Time Factors | 6 | 2010 | 6157 | 0.100 |
Why?
| Anti-Infective Agents, Local | 1 | 2012 | 40 | 0.100 |
Why?
| Biotin | 1 | 2012 | 20 | 0.100 |
Why?
| Barium | 4 | 1998 | 25 | 0.100 |
Why?
| Cloning, Molecular | 3 | 2001 | 524 | 0.100 |
Why?
| Mutagenesis, Site-Directed | 3 | 2005 | 345 | 0.090 |
Why?
| Fibroblasts | 3 | 1990 | 839 | 0.090 |
Why?
| Polymerase Chain Reaction | 2 | 2004 | 1000 | 0.090 |
Why?
| Sarcomeres | 2 | 2009 | 90 | 0.090 |
Why?
| Muscle Development | 4 | 1993 | 98 | 0.080 |
Why?
| Dantrolene | 1 | 2009 | 5 | 0.080 |
Why?
| Nifedipine | 1 | 2009 | 29 | 0.080 |
Why?
| Neuromuscular Diseases | 1 | 1990 | 89 | 0.080 |
Why?
| Point Mutation | 2 | 2001 | 217 | 0.080 |
Why?
| Hindlimb | 1 | 1989 | 130 | 0.080 |
Why?
| Night Blindness | 1 | 2008 | 6 | 0.080 |
Why?
| Calmodulin | 1 | 2008 | 71 | 0.080 |
Why?
| Ataxia | 1 | 2008 | 35 | 0.080 |
Why?
| Muscular Dystrophies | 1 | 1988 | 36 | 0.080 |
Why?
| In Vitro Techniques | 3 | 1997 | 1036 | 0.070 |
Why?
| Cytosol | 1 | 2008 | 208 | 0.070 |
Why?
| Embryo, Nonmammalian | 1 | 1988 | 173 | 0.070 |
Why?
| Embryo, Mammalian | 1 | 1988 | 214 | 0.070 |
Why?
| Heterozygote | 1 | 2008 | 251 | 0.070 |
Why?
| Mice, Inbred C57BL | 3 | 2012 | 4718 | 0.070 |
Why?
| Protein Interaction Mapping | 1 | 2007 | 102 | 0.070 |
Why?
| Biophysical Phenomena | 2 | 1997 | 63 | 0.070 |
Why?
| Temperature | 3 | 1985 | 578 | 0.070 |
Why?
| Biophysics | 2 | 1997 | 70 | 0.070 |
Why?
| Receptors, Cholinergic | 4 | 1990 | 41 | 0.070 |
Why?
| Genes, Lethal | 1 | 1986 | 26 | 0.070 |
Why?
| Chick Embryo | 3 | 1991 | 122 | 0.070 |
Why?
| Taste | 1 | 1988 | 209 | 0.070 |
Why?
| Analysis of Variance | 2 | 2012 | 1231 | 0.060 |
Why?
| Reference Values | 2 | 1996 | 748 | 0.060 |
Why?
| Xanthenes | 2 | 1994 | 11 | 0.060 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1997 | 104 | 0.060 |
Why?
| Ganglia, Spinal | 2 | 1996 | 42 | 0.060 |
Why?
| Aniline Compounds | 2 | 1994 | 71 | 0.060 |
Why?
| Age Factors | 3 | 2012 | 2900 | 0.060 |
Why?
| Genetic Predisposition to Disease | 1 | 2012 | 2109 | 0.060 |
Why?
| Potassium Channels | 2 | 1997 | 121 | 0.060 |
Why?
| Carrier Proteins | 1 | 2007 | 696 | 0.060 |
Why?
| Rats, Inbred Strains | 4 | 1985 | 376 | 0.060 |
Why?
| Light | 1 | 2005 | 335 | 0.050 |
Why?
| Magnesium | 1 | 2003 | 145 | 0.050 |
Why?
| Fluorescent Dyes | 2 | 1994 | 300 | 0.050 |
Why?
| RNA, Messenger | 3 | 1998 | 2563 | 0.050 |
Why?
| Isradipine | 2 | 1995 | 4 | 0.050 |
Why?
| Models, Structural | 3 | 1997 | 37 | 0.050 |
Why?
| Receptors, Adrenergic, beta | 1 | 2022 | 133 | 0.050 |
Why?
| Allosteric Regulation | 1 | 2001 | 82 | 0.050 |
Why?
| Restriction Mapping | 2 | 1999 | 77 | 0.050 |
Why?
| Amiloride | 2 | 1992 | 23 | 0.050 |
Why?
| Cyclic GMP | 2 | 1978 | 78 | 0.050 |
Why?
| Culture Techniques | 2 | 1991 | 80 | 0.050 |
Why?
| Two-Hybrid System Techniques | 1 | 2000 | 52 | 0.050 |
Why?
| Tetrodotoxin | 3 | 1990 | 40 | 0.040 |
Why?
| Microscopy, Electron | 3 | 2012 | 410 | 0.040 |
Why?
| Peptides | 2 | 1996 | 849 | 0.040 |
Why?
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 1999 | 9 | 0.040 |
Why?
| Tetraethylammonium Compounds | 2 | 1990 | 9 | 0.040 |
Why?
| Phosphodiesterase Inhibitors | 1 | 2000 | 82 | 0.040 |
Why?
| Heart Failure | 1 | 2012 | 1962 | 0.040 |
Why?
| Protein Folding | 1 | 2001 | 239 | 0.040 |
Why?
| Conserved Sequence | 2 | 1997 | 218 | 0.040 |
Why?
| Mice, Inbred Strains | 1 | 2000 | 398 | 0.040 |
Why?
| Heart Rate | 1 | 2022 | 705 | 0.040 |
Why?
| Oligopeptides | 1 | 2000 | 234 | 0.040 |
Why?
| omega-Agatoxin IVA | 1 | 1998 | 1 | 0.040 |
Why?
| Amino Acid Substitution | 1 | 1999 | 262 | 0.040 |
Why?
| Microscopy, Fluorescence | 1 | 2000 | 398 | 0.040 |
Why?
| Zebrafish | 1 | 2022 | 411 | 0.040 |
Why?
| Microelectrodes | 2 | 2012 | 32 | 0.040 |
Why?
| Spider Venoms | 1 | 1998 | 12 | 0.040 |
Why?
| Cell Nucleus | 1 | 2001 | 556 | 0.040 |
Why?
| Cell Compartmentation | 1 | 1998 | 52 | 0.040 |
Why?
| Mice, Inbred C3H | 1 | 1998 | 242 | 0.040 |
Why?
| Saccharomyces cerevisiae | 1 | 2001 | 477 | 0.040 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 1998 | 130 | 0.040 |
Why?
| Gene Expression | 1 | 2003 | 1424 | 0.040 |
Why?
| Shaker Superfamily of Potassium Channels | 1 | 1997 | 2 | 0.040 |
Why?
| Mutagenesis, Insertional | 1 | 1997 | 61 | 0.040 |
Why?
| Electrochemistry | 1 | 1997 | 78 | 0.040 |
Why?
| Macromolecular Substances | 1 | 1997 | 200 | 0.040 |
Why?
| Sequence Alignment | 1 | 1997 | 325 | 0.030 |
Why?
| Nimodipine | 1 | 1996 | 7 | 0.030 |
Why?
| Protein Multimerization | 1 | 2017 | 160 | 0.030 |
Why?
| Leucine | 1 | 1997 | 107 | 0.030 |
Why?
| Papillary Muscles | 1 | 1996 | 14 | 0.030 |
Why?
| Peptide Fragments | 1 | 2000 | 668 | 0.030 |
Why?
| Gap Junctions | 1 | 1997 | 58 | 0.030 |
Why?
| Protein Transport | 1 | 2017 | 398 | 0.030 |
Why?
| Blood | 1 | 1996 | 97 | 0.030 |
Why?
| Molecular Structure | 1 | 1997 | 438 | 0.030 |
Why?
| Snakes | 2 | 1986 | 20 | 0.030 |
Why?
| Models, Molecular | 1 | 2000 | 1379 | 0.030 |
Why?
| Cadmium Chloride | 1 | 1995 | 4 | 0.030 |
Why?
| Barium Compounds | 1 | 1995 | 7 | 0.030 |
Why?
| Lanthanum | 1 | 1995 | 8 | 0.030 |
Why?
| Cadmium | 1 | 1995 | 58 | 0.030 |
Why?
| Reaction Time | 1 | 1996 | 374 | 0.030 |
Why?
| omega-Conotoxin GVIA | 1 | 1994 | 3 | 0.030 |
Why?
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 1994 | 9 | 0.030 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1994 | 17 | 0.030 |
Why?
| Cell Membrane Permeability | 1 | 1994 | 83 | 0.030 |
Why?
| Cell Culture Techniques | 1 | 1997 | 344 | 0.030 |
Why?
| Chlorides | 1 | 1995 | 127 | 0.030 |
Why?
| Phosphorylation | 1 | 1998 | 1574 | 0.030 |
Why?
| Membranes | 1 | 1994 | 18 | 0.030 |
Why?
| Egtazic Acid | 1 | 1994 | 44 | 0.030 |
Why?
| Heterocyclic Compounds, 3-Ring | 1 | 1994 | 29 | 0.030 |
Why?
| Swine | 1 | 1996 | 705 | 0.030 |
Why?
| Synapses | 2 | 1996 | 330 | 0.030 |
Why?
| 3T3 Cells | 1 | 1993 | 140 | 0.030 |
Why?
| Mathematics | 2 | 1983 | 100 | 0.030 |
Why?
| Nicotinic Acids | 1 | 1992 | 6 | 0.030 |
Why?
| Water Pollutants | 1 | 2012 | 18 | 0.030 |
Why?
| Protein Structure, Quaternary | 1 | 2012 | 115 | 0.030 |
Why?
| Cyprinidae | 1 | 2012 | 19 | 0.030 |
Why?
| Organ Specificity | 1 | 1993 | 270 | 0.030 |
Why?
| Genes, Dominant | 1 | 2012 | 94 | 0.030 |
Why?
| Algorithms | 1 | 1999 | 1488 | 0.030 |
Why?
| Mutagenesis | 1 | 1992 | 170 | 0.020 |
Why?
| Anesthetics | 1 | 2012 | 56 | 0.020 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1991 | 152 | 0.020 |
Why?
| Body Temperature | 1 | 2012 | 210 | 0.020 |
Why?
| Tetraethylammonium | 1 | 1990 | 15 | 0.020 |
Why?
| Cell Death | 1 | 1992 | 324 | 0.020 |
Why?
| 4-Aminopyridine | 1 | 1990 | 21 | 0.020 |
Why?
| Male | 5 | 2008 | 55814 | 0.020 |
Why?
| Peptides, Cyclic | 1 | 1992 | 254 | 0.020 |
Why?
| Phylogeny | 1 | 1993 | 796 | 0.020 |
Why?
| beta-Galactosidase | 1 | 1989 | 62 | 0.020 |
Why?
| Extremities | 1 | 1990 | 113 | 0.020 |
Why?
| Tropomyosin | 1 | 1989 | 12 | 0.020 |
Why?
| Gestational Age | 1 | 1992 | 758 | 0.020 |
Why?
| Freeze Fracturing | 2 | 2002 | 7 | 0.020 |
Why?
| DNA Probes | 1 | 1989 | 59 | 0.020 |
Why?
| Sarcolemma | 1 | 1989 | 29 | 0.020 |
Why?
| Verapamil | 1 | 1989 | 32 | 0.020 |
Why?
| Muscular Dystrophy, Animal | 1 | 1989 | 8 | 0.020 |
Why?
| Creatine Kinase | 1 | 1989 | 75 | 0.020 |
Why?
| Embryonic and Fetal Development | 1 | 1989 | 94 | 0.020 |
Why?
| Nucleic Acid Hybridization | 1 | 1989 | 188 | 0.020 |
Why?
| Myosins | 1 | 1989 | 128 | 0.020 |
Why?
| Necturus | 1 | 1988 | 14 | 0.020 |
Why?
| Base Sequence | 1 | 1992 | 2120 | 0.020 |
Why?
| Stem Cell Transplantation | 1 | 1990 | 151 | 0.020 |
Why?
| Genetic Markers | 1 | 1989 | 323 | 0.020 |
Why?
| Dystrophin | 1 | 1988 | 30 | 0.020 |
Why?
| Stereoisomerism | 1 | 1988 | 91 | 0.020 |
Why?
| Amino Acid Motifs | 1 | 2008 | 198 | 0.020 |
Why?
| Genes | 1 | 1988 | 224 | 0.020 |
Why?
| Brain | 2 | 1997 | 2378 | 0.020 |
Why?
| Motor Activity | 1 | 2012 | 643 | 0.020 |
Why?
| Dimerization | 1 | 2008 | 176 | 0.020 |
Why?
| Chromosome Mapping | 1 | 1988 | 490 | 0.020 |
Why?
| Actins | 1 | 1989 | 383 | 0.020 |
Why?
| Transcription, Genetic | 1 | 1993 | 1317 | 0.020 |
Why?
| Female | 2 | 2008 | 59720 | 0.020 |
Why?
| Histological Techniques | 1 | 1986 | 40 | 0.020 |
Why?
| Tissue Distribution | 1 | 1986 | 286 | 0.020 |
Why?
| Stem Cells | 1 | 1990 | 547 | 0.020 |
Why?
| Cations | 1 | 2005 | 79 | 0.020 |
Why?
| Biological Transport, Active | 1 | 1985 | 71 | 0.020 |
Why?
| Tendons | 1 | 1986 | 120 | 0.020 |
Why?
| Cysteine | 1 | 2005 | 171 | 0.010 |
Why?
| Rubidium | 1 | 1983 | 12 | 0.010 |
Why?
| Kidney | 1 | 1989 | 1188 | 0.010 |
Why?
| Evoked Potentials | 1 | 1983 | 108 | 0.010 |
Why?
| Cell Differentiation | 1 | 1989 | 1700 | 0.010 |
Why?
| Liver | 1 | 1989 | 1688 | 0.010 |
Why?
| Pregnancy | 1 | 1992 | 5525 | 0.010 |
Why?
| Rana pipiens | 2 | 1978 | 16 | 0.010 |
Why?
| Tumor Cells, Cultured | 2 | 1993 | 851 | 0.010 |
Why?
| Thoracica | 1 | 1977 | 3 | 0.010 |
Why?
| Potassium Chloride | 1 | 1977 | 35 | 0.010 |
Why?
| Glutamates | 1 | 1977 | 58 | 0.010 |
Why?
| Ethylamines | 1 | 1976 | 4 | 0.010 |
Why?
| Organ Culture Techniques | 1 | 1996 | 141 | 0.010 |
Why?
| Lidocaine | 1 | 1976 | 41 | 0.010 |
Why?
| Methylamines | 1 | 1976 | 30 | 0.010 |
Why?
| Gene Targeting | 1 | 1996 | 75 | 0.010 |
Why?
| Ca(2+) Mg(2+)-ATPase | 1 | 1989 | 2 | 0.010 |
Why?
| Calsequestrin | 1 | 1989 | 7 | 0.010 |
Why?
| Calcium-Transporting ATPases | 1 | 1989 | 35 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1988 | 65 | 0.000 |
Why?
| Molecular Weight | 1 | 1989 | 331 | 0.000 |
Why?
| Pheochromocytoma | 1 | 1989 | 54 | 0.000 |
Why?
| Cell Communication | 1 | 1989 | 280 | 0.000 |
Why?
| Anura | 1 | 1978 | 42 | 0.000 |
Why?
| Cyclic AMP | 1 | 1978 | 226 | 0.000 |
Why?
|
|
Beam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|